Clinical TrialsSearch results
Number of results: 67288
Completed
- A phase II study to evaluate prophylactic treatment of dacomitinib-induced dermatologic adverse events in EGFR-mutated advanced non-small cell lung cancer
- non-small cell lung cancer
- Takayama Koichi
- 2019-07-08
Completed
- A Phase II Trial of Biweekly Nab-PaclitaXel in Combination with Ramcirumab for metastatic Gastric Cancer or Gastro-oesophageal Junction Adenocarcinoma
- gastric cancer
- IZAWA Naoki
- 2018-12-21
Completed
- A phase II trial of CHOP-14 with Mogamulizumab for untreated elderly patients with CCR4 positive adult T-cell leukemia/lymphoma
- Adult T-cell leukemia lymphoma
- Ishitsuka Kenji
- 2019-03-26
Completed
- A phase II trial of GnP down staging chemotherapy for patients with locally advanced pancreatic cancer(CAP-005)
- Pancreatic cancer
- Ohtsuka Masayuki
- 2019-03-18
Completed
- A phase II trial of osimertinib for elderly patients with advanced or postoperative recurrent non-small-cell lung cancer
- non-small cell lung cancer
- Takayama Koichi
- 2018-11-14
Completed
- A phase II trial of TAS-102 in combination with cetuximab for metastatic colorectal cancer patients
- Metastatic RAS wild type colorectal cancer with refractory or intolerable to standard chemotherapy
- Izawa Naoki
- 2019-03-29
Completed
- A Phase II/III Investigator Initiated Clinical Traial Evaluating the Efficacy and Safety of Remimazolam in Japanese Patients Undergoing Gastrointestinal Endoscopy
- Japanese patients undergoing upper gastrointestinal endoscopy or colonoscopy without analgesics
- Ikehara Hisatomo
- 2021-02-15
Completed
- A Phase II/III Study of MR19A13A.
- Patients undergoing a scheduled surgery under general anesthesia.with mask induction.
- Nobuyo Oya
- 2022-10-27
Completed
- A Phase II/III Study of Sargramostim
- Coronavirus disease-2019 (COVID-19)
- Taniguchi Masaki
- 2020-11-04
Completed
- A phase II/III, randomized, active-comparator, observer-blind, non-inferiority study to demonstrate the immunogenicity and safety of DS-5670a/b in children 5 through 11 years of age.
- Prevention of infectious disease by Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)
- Inoguchi Akihiro
- 2022-10-20